We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+7.7%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$521M
AUM Growth
+$64M
Cap. Flow
+$31.7M
Cap. Flow %
6.08%
Top 10 Hldgs %
25.71%
Holding
256
New
50
Increased
81
Reduced
62
Closed
52

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$14.6M
2
MET icon
MetLife
MET
+$9.19M
3
WBA
Walgreens Boots Alliance
WBA
+$9.05M
4
C icon
Citigroup
C
+$8.2M
5
TGT icon
Target
TGT
+$7.95M

Sector Composition

Rank Sector Weight
1 Technology 17.67%
2 Financials 16%
3 Healthcare 11.72%
4 Industrials 8.96%
5 Consumer Discretionary 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NE
76
DELISTED
Noble Corporation
NE
$2.18M 0.42%
66,434
+1,258
+2% +$41.8K
MRO
77
DELISTED
Marathon Oil Corporation
MRO
$2.12M 0.41%
59,940
+1,600
+3% +$57.1K
NDAQ icon
78
Nasdaq
NDAQ
$52.9B
$2.1M 0.4%
158,304
+4,500
+3% +$55K
CMLS
79
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$1.52M 0.29%
24,660
-250
-1% -$12.8K
HST icon
80
Host Hotels & Resorts
HST
$16B
$1.41M 0.27%
+72,329
New +$1.34M
SNDK
81
DELISTED
SANDISK CORP
SNDK
$1.31M 0.25%
18,611
-14,435
-44% -$973K
LNW
82
DELISTED
Light & Wonder
LNW
$1.2M 0.23%
70,859
-400
-0.6% -$7.06K
DCH
83
Dauch Corp
DCH
$1.51B
$1.17M 0.22%
57,103
+10,941
+24% +$209K
NKTR icon
84
Nektar Therapeutics
NKTR
$2.58B
$1.11M 0.21%
6,506
+1,203
+23% +$194K
LTM
85
DELISTED
LIFE TIME FITNESS INC
LTM
$1.1M 0.21%
+23,404
New +$1.12M
PAG icon
86
Penske Automotive Group
PAG
$14.2B
$1.01M 0.19%
21,474
+3,326
+18% +$142K
OPK icon
87
Opko Health
OPK
$1.02B
$996K 0.19%
118,020
-19,687
-14% -$199K
PMCS
88
DELISTED
P M C SIERRA INC
PMCS
$977K 0.19%
151,907
+100,882
+198% +$625K
HXL icon
89
Hexcel
HXL
$7.82B
$960K 0.18%
21,488
-150
-0.7% -$6.34K
CLDX icon
90
Celldex Therapeutics
CLDX
$3.28B
$958K 0.18%
2,638
+1,211
+85% +$467K
REV
91
DELISTED
Revlon, Inc.
REV
$931K 0.18%
+37,305
New +$951K
IDTI
92
DELISTED
Integrated Device Technology I
IDTI
$891K 0.17%
87,487
-14,723
-14% -$147K
BFAM icon
93
Bright Horizons
BFAM
$3.86B
$876K 0.17%
+23,841
New +$857K
PTC icon
94
PTC
PTC
$16B
$867K 0.17%
+24,486
New +$752K
FLTX
95
DELISTED
Fleetmatics Group PLC
FLTX
$864K 0.17%
+19,969
New +$730K
RATE
96
DELISTED
Bankrate Inc
RATE
$833K 0.16%
46,447
+4,800
+12% +$92.6K
CNC icon
97
Centene
CNC
$32.5B
$804K 0.15%
+54,568
New +$816K
GTS
98
DELISTED
Triple-S Management Corporation
GTS
$793K 0.15%
42,891
-211
-0.5% -$3.78K
NPSP
99
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$755K 0.14%
+24,878
New +$685K
SREV
100
DELISTED
ServiceSource International, Inc.
SREV
$720K 0.14%
+85,904
New +$863K

Similar funds

Stoneridge Investment Partners's Q4 2013 Portfolio in Review

As of Q4 2013, Stoneridge Investment Partners held 256 positions worth $521M, up 14% from $457M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Stoneridge Investment Partners deployed $31.7M of net new capital in Q4 2013, opening 50 new positions and adding to 81 existing holdings. Its largest new stake was Mondelez International: 285,413 shares worth $10.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Target, an estimated $7.95M trimmed.

  • Stoneridge Investment Partners's largest Q4 2013 buy was Mondelez International: 285,413 shares worth $10.1M.
  • Stoneridge Investment Partners added most to Twenty-First Century Fox, Inc. Class A in Q4 2013, an estimated $9.61M increase.
  • Stoneridge Investment Partners's biggest Q4 2013 reduction was Target, cutting an estimated $7.95M.
  • Stoneridge Investment Partners fully exited AbbVie in Q4 2013, selling an estimated $14.6M.
  • Stoneridge Investment Partners's ten largest holdings make up 26% of its $521M portfolio in Q4 2013.
  • Stoneridge Investment Partners opened 50 new positions and closed 52 in Q4 2013.
  • Stoneridge Investment Partners's portfolio value rose 14% quarter-over-quarter to $521M.

Based on Stoneridge Investment Partners's 13F filing for Q4 2013, filed 14 Jan 2014.